Please assess the completion status of the following clinical trial:

Trial Title: INCA: Intracranial Aneurysm Treatment With NeXsys

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-80 years at screening~* Unruptured saccular IA in the anterior or posterior circulation with dimensions consistent with Table 2~* IA appears suitable for NeXsys device~* Patient willing to comply with study requirements~* Patient able to understand and sign a study-specific informed consent form~Exclusion Criteria:~* Ruptured IA~* Any other IA that requires treatment in the next year~* IA width \>10 mm~* IA neck \>9 mm~* IA has important flow from its base such that occluding the IA would cause stroke~* Target IA contains any device (e.g., coils)~* Inability to access the target IA with microcatheter~* Any congenital or iatrogenic coagulopathy~* Platelet count \<50,000/microliter~* Known allergy to platinum, nickel or titanium~* Known allergy to contrast agents~* Stenosis of the target IA's parent vessel \>50%~* Taking daily aspirin or other platelet inhibitor (clopidogrel or equivalent)~* Taking any anticoagulants (e.g., warfarin)~* Pregnant or planning pregnancy in the next 2 years~* Other medical conditions that could increase the risk of neurovascular procedures (e.g., liver failure, cancer, etc.)~* Participating in another study with investigational devices or drugs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Placement of study device (currently called NeXsys) into target aneurysm via standard endovascular procedure.

Based on this trial design, predict the completion outcome and termination type (if applicable).